Share Price and Basic Stock Data
Last Updated: November 14, 2025, 10:24 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Sundaram Multi Pap Ltd operates in the Printing/Publishing/Stationery sector, with its share price reported at ₹1.91 and a market capitalization of ₹90.5 Cr. The company has experienced fluctuating sales figures over the past quarters, with a notable rise in revenue in the March 2023 quarter, which recorded sales of ₹41.01 Cr, jumping to ₹42.29 Cr in June 2023. However, the sales dipped to ₹22.30 Cr in September 2023, reflecting a 47% decline quarter-on-quarter. Despite this volatility, the annual sales figures show a modest recovery, with ₹114 Cr reported for March 2023, increasing slightly to ₹127 Cr for both March 2024 and March 2025. The trailing twelve months (TTM) revenue stands at ₹126 Cr. This indicates a pattern of inconsistent performance, which may be a concern for investors seeking stability in revenue generation.
Profitability and Efficiency Metrics
The profitability metrics of Sundaram Multi Pap Ltd reveal significant challenges. The company reported a net profit of ₹-6 Cr, reflecting ongoing operational difficulties. The operating profit margin (OPM) stood at 2.80%, which is low compared to industry standards, indicating tight margins. Quarterly performance has been particularly erratic, with operating profits fluctuating, including a loss of ₹1.16 Cr in March 2025. The return on equity (ROE) is reported at 5.92%, while return on capital employed (ROCE) is considerably lower at 2.20%, suggesting inefficient capital utilization. Additionally, the interest coverage ratio (ICR) of 2.28x indicates that while the company can cover its interest obligations, the margin is narrow, raising potential concerns about financial health in the event of revenue downturns.
Balance Sheet Strength and Financial Ratios
Sundaram Multi Pap Ltd’s balance sheet reflects a mixed picture of financial health. The company reported total borrowings of ₹27 Cr against reserves of ₹40 Cr, providing a modest buffer for financial stability. The price-to-book value (P/BV) ratio is reported at 0.60x, indicating that the stock may be undervalued relative to its book value, which is often a positive signal for investors. However, the cash conversion cycle (CCC) of 159 days suggests inefficiencies in managing working capital, particularly when compared to typical sector norms. The company’s total liabilities have decreased from ₹299 Cr in March 2014 to ₹122 Cr in March 2025, indicating a positive trend towards deleveraging. Still, the diminishing ROCE, which stood at -2% for March 2025, highlights ongoing challenges in generating returns on capital employed.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sundaram Multi Pap Ltd indicates a predominantly public ownership, with public shareholders holding 68.83% of the stake. Promoters maintain a stable shareholding of 31.11%, which has seen minimal fluctuation over recent periods. The presence of domestic institutional investors (DIIs) is negligible at 0.05%, indicating limited institutional interest, which could be a concern for potential investors looking for robust support. The number of shareholders has grown steadily, reaching 95,597 by June 2025, suggesting an increasing interest among retail investors. However, the lack of foreign institutional investment (FIIs) could signal caution regarding international confidence in the company. This concentration of public ownership may also imply a higher sensitivity to market sentiment and operational performance.
Outlook, Risks, and Final Insight
The outlook for Sundaram Multi Pap Ltd appears mixed, characterized by both opportunities and risks. On the positive side, the company’s ability to stabilize revenue at ₹127 Cr for the past two fiscal years indicates some resilience. However, the volatility in quarterly sales and profitability metrics raises significant risks. Continued losses, particularly in net profit, and low ROCE threaten to undermine investor confidence. Additionally, the high cash conversion cycle may place strain on liquidity, hampering operational agility. Investors should closely monitor the company’s performance in managing costs and improving operational efficiencies. If Sundaram Multi Pap Ltd can navigate these challenges effectively, it might leverage its undervalued stock status to attract more institutional interest and restore profitability, ultimately enhancing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Sundaram Multi Pap Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| H T Media Ltd | 594 Cr. | 25.5 | 28.6/14.5 | 27.6 | 71.0 | 0.00 % | 2.51 % | 0.03 % | 2.00 |
| Gala Global Products Ltd | 13.8 Cr. | 2.52 | 4.25/2.37 | 6.97 | 0.00 % | 2.28 % | 13.0 % | 5.00 | |
| Flair Writing Industries Ltd | 3,361 Cr. | 319 | 357/194 | 28.4 | 100.0 | 0.31 % | 15.6 % | 11.9 % | 5.00 |
| Doms Industries Ltd | 15,910 Cr. | 2,622 | 3,115/2,092 | 74.1 | 181 | 0.12 % | 26.2 % | 22.3 % | 10.0 |
| DB Corp Ltd | 4,631 Cr. | 260 | 344/189 | 13.4 | 129 | 4.62 % | 21.1 % | 16.7 % | 10.0 |
| Industry Average | 2,635.19 Cr | 436.44 | 79.30 | 207.33 | 1.07% | 9.42% | 9.72% | 6.27 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.96 | 25.38 | 22.02 | 41.01 | 42.29 | 22.30 | 21.94 | 40.51 | 42.42 | 24.00 | 21.36 | 39.65 | 40.66 |
| Expenses | 21.18 | 21.85 | 22.11 | 39.98 | 40.06 | 22.54 | 22.41 | 37.93 | 38.69 | 24.04 | 22.26 | 40.81 | 39.52 |
| Operating Profit | 4.78 | 3.53 | -0.09 | 1.03 | 2.23 | -0.24 | -0.47 | 2.58 | 3.73 | -0.04 | -0.90 | -1.16 | 1.14 |
| OPM % | 18.41% | 13.91% | -0.41% | 2.51% | 5.27% | -1.08% | -2.14% | 6.37% | 8.79% | -0.17% | -4.21% | -2.93% | 2.80% |
| Other Income | 0.77 | 0.46 | 0.72 | -0.58 | -1.16 | -0.32 | 0.38 | -0.48 | -1.79 | -0.10 | 0.10 | 2.06 | 0.16 |
| Interest | 1.35 | 1.02 | 1.14 | 0.59 | 0.93 | 0.77 | 0.98 | 0.78 | 0.62 | 0.61 | 0.79 | 0.66 | 0.70 |
| Depreciation | 0.97 | 0.97 | 0.97 | 0.98 | 0.97 | 1.02 | 1.07 | 1.08 | 1.06 | 1.09 | 1.10 | 1.09 | 1.04 |
| Profit before tax | 3.23 | 2.00 | -1.48 | -1.12 | -0.83 | -2.35 | -2.14 | 0.24 | 0.26 | -1.84 | -2.69 | -0.85 | -0.44 |
| Tax % | 0.00% | 0.00% | 5.41% | -3.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 3.23 | 2.00 | -1.56 | -1.07 | -0.83 | -2.35 | -2.14 | 0.24 | 0.25 | -1.83 | -2.69 | -0.85 | -0.44 |
| EPS in Rs | 0.07 | 0.04 | -0.03 | -0.02 | -0.02 | -0.05 | -0.05 | 0.01 | 0.01 | -0.04 | -0.06 | -0.02 | -0.01 |
Last Updated: August 20, 2025, 2:55 am
Below is a detailed analysis of the quarterly data for Sundaram Multi Pap Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 40.66 Cr.. The value appears strong and on an upward trend. It has increased from 39.65 Cr. (Mar 2025) to 40.66 Cr., marking an increase of 1.01 Cr..
- For Expenses, as of Jun 2025, the value is 39.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.81 Cr. (Mar 2025) to 39.52 Cr., marking a decrease of 1.29 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.14 Cr.. The value appears strong and on an upward trend. It has increased from -1.16 Cr. (Mar 2025) to 1.14 Cr., marking an increase of 2.30 Cr..
- For OPM %, as of Jun 2025, the value is 2.80%. The value appears strong and on an upward trend. It has increased from -2.93% (Mar 2025) to 2.80%, marking an increase of 5.73%.
- For Other Income, as of Jun 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 2.06 Cr. (Mar 2025) to 0.16 Cr., marking a decrease of 1.90 Cr..
- For Interest, as of Jun 2025, the value is 0.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.66 Cr. (Mar 2025) to 0.70 Cr., marking an increase of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 1.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.09 Cr. (Mar 2025) to 1.04 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.85 Cr. (Mar 2025) to -0.44 Cr., marking an increase of 0.41 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.44 Cr.. The value appears strong and on an upward trend. It has increased from -0.85 Cr. (Mar 2025) to -0.44 Cr., marking an increase of 0.41 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.01. The value appears strong and on an upward trend. It has increased from -0.02 (Mar 2025) to -0.01, marking an increase of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 154 | 83 | 96 | 94 | 106 | 100 | 97 | 51 | 70 | 114 | 127 | 127 | 128 |
| Expenses | 135 | 82 | 84 | 79 | 95 | 85 | 90 | 52 | 59 | 105 | 123 | 126 | 127 |
| Operating Profit | 19 | 1 | 12 | 15 | 12 | 15 | 7 | -1 | 11 | 10 | 4 | 2 | 1 |
| OPM % | 12% | 1% | 12% | 16% | 11% | 15% | 7% | -3% | 16% | 8% | 3% | 1% | 1% |
| Other Income | 3 | 0 | -4 | -8 | -16 | 2 | 5 | 2 | 2 | 1 | -2 | 0 | 2 |
| Interest | 17 | 16 | 12 | 10 | 9 | 7 | 10 | 6 | 5 | 4 | 4 | 3 | 2 |
| Depreciation | 5 | 3 | 3 | 2 | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 1 | -17 | -8 | -5 | -15 | 6 | -3 | -9 | 4 | 3 | -5 | -5 | -3 |
| Tax % | 85% | -4% | -18% | -0% | 0% | 0% | 0% | -2% | 3% | 2% | 0% | 0% | |
| Net Profit | 0 | -17 | -6 | -5 | -15 | 6 | -3 | -9 | 4 | 3 | -5 | -5 | -3 |
| EPS in Rs | 0.00 | -0.78 | -0.30 | -0.20 | -0.55 | 0.22 | -0.10 | -0.19 | 0.08 | 0.05 | -0.11 | -0.11 | -0.07 |
| Dividend Payout % | 216% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 64.71% | 16.67% | -200.00% | 140.00% | -150.00% | -200.00% | 144.44% | -25.00% | -266.67% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -48.04% | -216.67% | 340.00% | -290.00% | -50.00% | 344.44% | -169.44% | -241.67% | 266.67% |
Sundaram Multi Pap Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 6% |
| 3 Years: | 22% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | % |
| TTM: | -281% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 9% |
| 3 Years: | -15% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -1% |
| 3 Years: | 0% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: June 16, 2025, 11:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 22 | 22 | 22 | 25 | 27 | 47 | 47 | 47 | 47 | 47 | 47 | 47 |
| Reserves | 137 | 91 | 80 | 79 | 69 | 55 | 52 | 44 | 48 | 50 | 45 | 40 |
| Borrowings | 116 | 103 | 91 | 64 | 56 | 43 | 45 | 44 | 39 | 35 | 32 | 27 |
| Other Liabilities | 24 | 17 | 14 | 30 | 23 | 17 | 13 | 13 | 12 | 6 | 10 | 7 |
| Total Liabilities | 299 | 232 | 207 | 196 | 175 | 163 | 158 | 148 | 146 | 138 | 135 | 122 |
| Fixed Assets | 131 | 96 | 87 | 54 | 53 | 67 | 64 | 60 | 57 | 71 | 69 | 51 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 15 | 15 | 25 | 39 | 39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 153 | 121 | 94 | 104 | 84 | 96 | 94 | 88 | 89 | 67 | 65 | 71 |
| Total Assets | 299 | 232 | 207 | 196 | 175 | 163 | 158 | 148 | 146 | 138 | 135 | 122 |
Below is a detailed analysis of the balance sheet data for Sundaram Multi Pap Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 47.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 47.00 Cr..
- For Reserves, as of Mar 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Mar 2024) to 40.00 Cr., marking a decrease of 5.00 Cr..
- For Borrowings, as of Mar 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 32.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 5.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing). It has decreased from 10.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 3.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 122.00 Cr.. The value appears to be improving (decreasing). It has decreased from 135.00 Cr. (Mar 2024) to 122.00 Cr., marking a decrease of 13.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 69.00 Cr. (Mar 2024) to 51.00 Cr., marking a decrease of 18.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 71.00 Cr.. The value appears strong and on an upward trend. It has increased from 65.00 Cr. (Mar 2024) to 71.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Mar 2025, the value is 122.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Mar 2024) to 122.00 Cr., marking a decrease of 13.00 Cr..
Notably, the Reserves (40.00 Cr.) exceed the Borrowings (27.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -97.00 | -102.00 | -79.00 | -49.00 | -44.00 | -28.00 | -38.00 | -45.00 | -28.00 | -25.00 | -28.00 | -25.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 95 | 103 | 96 | 56 | 78 | 64 | 126 | 82 | 40 | 34 | 42 |
| Inventory Days | 191 | 340 | 207 | 131 | 173 | 213 | 201 | 301 | 283 | 155 | 151 | 128 |
| Days Payable | 44 | 50 | 47 | 65 | 83 | 45 | 13 | 51 | 28 | 11 | 24 | 11 |
| Cash Conversion Cycle | 262 | 385 | 263 | 162 | 146 | 246 | 252 | 376 | 337 | 185 | 161 | 159 |
| Working Capital Days | 80 | 225 | 45 | 60 | 51 | 156 | 216 | 369 | 276 | 156 | 134 | 78 |
| ROCE % | 7% | 1% | 6% | 8% | 8% | 9% | 3% | -2% | 8% | 7% | 0% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Mar 15 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.21 | -0.73 | -0.27 | -0.40 | -1.05 |
| Diluted EPS (Rs.) | 0.21 | -0.73 | -0.27 | -0.40 | -1.05 |
| Cash EPS (Rs.) | 0.34 | -0.59 | -0.12 | -0.21 | -0.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 3.53 | 2.56 | 3.28 | 3.79 | 4.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 3.53 | 2.56 | 3.28 | 3.79 | 4.41 |
| Revenue From Operations / Share (Rs.) | 3.67 | 4.00 | 4.04 | 4.57 | 3.94 |
| PBDIT / Share (Rs.) | 0.61 | 0.54 | 0.78 | 0.59 | 0.06 |
| PBIT / Share (Rs.) | 0.51 | 0.44 | 0.66 | 0.41 | -0.18 |
| PBT / Share (Rs.) | 0.24 | -0.56 | -0.18 | -0.47 | -1.09 |
| Net Profit / Share (Rs.) | 0.24 | -0.69 | -0.25 | -0.40 | -1.05 |
| NP After MI And SOA / Share (Rs.) | 0.24 | -0.69 | -0.25 | -0.40 | -1.05 |
| PBDIT Margin (%) | 16.90 | 13.68 | 19.42 | 13.08 | 1.57 |
| PBIT Margin (%) | 14.05 | 11.20 | 16.34 | 9.03 | -4.65 |
| PBT Margin (%) | 6.63 | -14.01 | -4.67 | -10.32 | -27.56 |
| Net Profit Margin (%) | 6.63 | -17.36 | -6.21 | -8.84 | -26.69 |
| NP After MI And SOA Margin (%) | 6.63 | -17.36 | -6.21 | -8.84 | -26.69 |
| Return on Networth / Equity (%) | 8.75 | -27.09 | -7.66 | -10.67 | -23.85 |
| Return on Capital Employeed (%) | 14.51 | 15.30 | 16.87 | 8.41 | -2.70 |
| Return On Assets (%) | 4.28 | -12.41 | -3.46 | -4.58 | -10.36 |
| Long Term Debt / Equity (X) | 0.00 | 0.13 | 0.18 | 0.26 | 0.49 |
| Total Debt / Equity (X) | 0.49 | 0.76 | 0.76 | 0.83 | 0.90 |
| Asset Turnover Ratio (%) | 0.59 | 0.60 | 0.48 | 0.45 | 0.32 |
| Current Ratio (X) | 1.63 | 1.31 | 1.29 | 1.03 | 1.45 |
| Quick Ratio (X) | 0.94 | 0.76 | 0.95 | 0.49 | 0.52 |
| Inventory Turnover Ratio (X) | 1.58 | 2.18 | 1.79 | 1.10 | 0.92 |
| Interest Coverage Ratio (X) | 2.28 | 1.67 | 1.73 | 1.06 | 0.08 |
| Interest Coverage Ratio (Post Tax) (X) | 1.89 | 0.95 | 1.32 | 0.84 | -0.19 |
| Enterprise Value (Cr.) | 103.53 | 129.21 | 128.33 | 115.10 | 130.25 |
| EV / Net Operating Revenue (X) | 1.04 | 1.19 | 1.29 | 1.17 | 1.53 |
| EV / EBITDA (X) | 6.15 | 8.69 | 6.66 | 8.93 | 97.11 |
| MarketCap / Net Operating Revenue (X) | 0.46 | 0.70 | 0.67 | 0.49 | 0.53 |
| Price / BV (X) | 0.60 | 1.10 | 0.83 | 0.59 | 0.47 |
| Price / Net Operating Revenue (X) | 0.46 | 0.70 | 0.67 | 0.49 | 0.53 |
| EarningsYield | 0.14 | -0.24 | -0.09 | -0.17 | -0.50 |
After reviewing the key financial ratios for Sundaram Multi Pap Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 19, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 19, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -0.73 (Mar 18) to 0.21, marking an increase of 0.94.
- For Diluted EPS (Rs.), as of Mar 19, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -0.73 (Mar 18) to 0.21, marking an increase of 0.94.
- For Cash EPS (Rs.), as of Mar 19, the value is 0.34. This value is below the healthy minimum of 3. It has increased from -0.59 (Mar 18) to 0.34, marking an increase of 0.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 3.53. It has increased from 2.56 (Mar 18) to 3.53, marking an increase of 0.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 3.53. It has increased from 2.56 (Mar 18) to 3.53, marking an increase of 0.97.
- For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 3.67. It has decreased from 4.00 (Mar 18) to 3.67, marking a decrease of 0.33.
- For PBDIT / Share (Rs.), as of Mar 19, the value is 0.61. This value is below the healthy minimum of 2. It has increased from 0.54 (Mar 18) to 0.61, marking an increase of 0.07.
- For PBIT / Share (Rs.), as of Mar 19, the value is 0.51. This value is within the healthy range. It has increased from 0.44 (Mar 18) to 0.51, marking an increase of 0.07.
- For PBT / Share (Rs.), as of Mar 19, the value is 0.24. This value is within the healthy range. It has increased from -0.56 (Mar 18) to 0.24, marking an increase of 0.80.
- For Net Profit / Share (Rs.), as of Mar 19, the value is 0.24. This value is below the healthy minimum of 2. It has increased from -0.69 (Mar 18) to 0.24, marking an increase of 0.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 0.24. This value is below the healthy minimum of 2. It has increased from -0.69 (Mar 18) to 0.24, marking an increase of 0.93.
- For PBDIT Margin (%), as of Mar 19, the value is 16.90. This value is within the healthy range. It has increased from 13.68 (Mar 18) to 16.90, marking an increase of 3.22.
- For PBIT Margin (%), as of Mar 19, the value is 14.05. This value is within the healthy range. It has increased from 11.20 (Mar 18) to 14.05, marking an increase of 2.85.
- For PBT Margin (%), as of Mar 19, the value is 6.63. This value is below the healthy minimum of 10. It has increased from -14.01 (Mar 18) to 6.63, marking an increase of 20.64.
- For Net Profit Margin (%), as of Mar 19, the value is 6.63. This value is within the healthy range. It has increased from -17.36 (Mar 18) to 6.63, marking an increase of 23.99.
- For NP After MI And SOA Margin (%), as of Mar 19, the value is 6.63. This value is below the healthy minimum of 8. It has increased from -17.36 (Mar 18) to 6.63, marking an increase of 23.99.
- For Return on Networth / Equity (%), as of Mar 19, the value is 8.75. This value is below the healthy minimum of 15. It has increased from -27.09 (Mar 18) to 8.75, marking an increase of 35.84.
- For Return on Capital Employeed (%), as of Mar 19, the value is 14.51. This value is within the healthy range. It has decreased from 15.30 (Mar 18) to 14.51, marking a decrease of 0.79.
- For Return On Assets (%), as of Mar 19, the value is 4.28. This value is below the healthy minimum of 5. It has increased from -12.41 (Mar 18) to 4.28, marking an increase of 16.69.
- For Long Term Debt / Equity (X), as of Mar 19, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 18) to 0.00, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 19, the value is 0.49. This value is within the healthy range. It has decreased from 0.76 (Mar 18) to 0.49, marking a decrease of 0.27.
- For Asset Turnover Ratio (%), as of Mar 19, the value is 0.59. It has decreased from 0.60 (Mar 18) to 0.59, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 19, the value is 1.63. This value is within the healthy range. It has increased from 1.31 (Mar 18) to 1.63, marking an increase of 0.32.
- For Quick Ratio (X), as of Mar 19, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.76 (Mar 18) to 0.94, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 19, the value is 1.58. This value is below the healthy minimum of 4. It has decreased from 2.18 (Mar 18) to 1.58, marking a decrease of 0.60.
- For Interest Coverage Ratio (X), as of Mar 19, the value is 2.28. This value is below the healthy minimum of 3. It has increased from 1.67 (Mar 18) to 2.28, marking an increase of 0.61.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 1.89. This value is below the healthy minimum of 3. It has increased from 0.95 (Mar 18) to 1.89, marking an increase of 0.94.
- For Enterprise Value (Cr.), as of Mar 19, the value is 103.53. It has decreased from 129.21 (Mar 18) to 103.53, marking a decrease of 25.68.
- For EV / Net Operating Revenue (X), as of Mar 19, the value is 1.04. This value is within the healthy range. It has decreased from 1.19 (Mar 18) to 1.04, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 19, the value is 6.15. This value is within the healthy range. It has decreased from 8.69 (Mar 18) to 6.15, marking a decrease of 2.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 18) to 0.46, marking a decrease of 0.24.
- For Price / BV (X), as of Mar 19, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 18) to 0.60, marking a decrease of 0.50.
- For Price / Net Operating Revenue (X), as of Mar 19, the value is 0.46. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 18) to 0.46, marking a decrease of 0.24.
- For EarningsYield, as of Mar 19, the value is 0.14. This value is below the healthy minimum of 5. It has increased from -0.24 (Mar 18) to 0.14, marking an increase of 0.38.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sundaram Multi Pap Ltd:
- Net Profit Margin: 6.63%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.51% (Industry Average ROCE: 9.42%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.75% (Industry Average ROE: 9.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.89
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.94
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 79.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.49
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.63%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Printing/Publishing/Stationery | 5/6, Papa Industrial Estate, Mumbai Maharashtra 400093 | info@sundaramgroups.in http://www.sundaramgroups.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Amrut P Shah | Chairman & Managing Director |
| Mr. Shantilal P Shah | Whole Time Director |
| Mr. Krunal S Shah | Whole Time Director |
| Mr. Kalpesh B Parekh | Independent Director |
| Mr. Mahesh Devji Bhanushali | Independent Director |
| Ms. Jyoti C Gala | Independent Woman Director |
FAQ
What is the intrinsic value of Sundaram Multi Pap Ltd?
Sundaram Multi Pap Ltd's intrinsic value (as of 14 November 2025) is 1.05 which is 44.44% lower the current market price of 1.89, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 90.0 Cr. market cap, FY2025-2026 high/low of 2.97/1.52, reserves of ₹40 Cr, and liabilities of 122 Cr.
What is the Market Cap of Sundaram Multi Pap Ltd?
The Market Cap of Sundaram Multi Pap Ltd is 90.0 Cr..
What is the current Stock Price of Sundaram Multi Pap Ltd as on 14 November 2025?
The current stock price of Sundaram Multi Pap Ltd as on 14 November 2025 is 1.89.
What is the High / Low of Sundaram Multi Pap Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sundaram Multi Pap Ltd stocks is 2.97/1.52.
What is the Stock P/E of Sundaram Multi Pap Ltd?
The Stock P/E of Sundaram Multi Pap Ltd is .
What is the Book Value of Sundaram Multi Pap Ltd?
The Book Value of Sundaram Multi Pap Ltd is 1.45.
What is the Dividend Yield of Sundaram Multi Pap Ltd?
The Dividend Yield of Sundaram Multi Pap Ltd is 0.00 %.
What is the ROCE of Sundaram Multi Pap Ltd?
The ROCE of Sundaram Multi Pap Ltd is 2.20 %.
What is the ROE of Sundaram Multi Pap Ltd?
The ROE of Sundaram Multi Pap Ltd is 5.92 %.
What is the Face Value of Sundaram Multi Pap Ltd?
The Face Value of Sundaram Multi Pap Ltd is 1.00.